On January 8, 2024, Imbed Biosciences, Inc. closed the transaction. The company has raised $10,000,000 in funding. The company received $6,500,000 in second and final tranche.

The transaction was led by new investor, CVC fund jointly operated by Niterra Co., Ltd. leading the round and Pegasus Tech Ventures, Inc. The transaction also included strong participation from existing investors.